M0600000
美雌醇
European Pharmacopoeia (EP) Reference Standard
别名:
17α-乙炔基-1,3,5(10)-雌三烯-3,17β-二醇 3-甲醚, 17α-乙炔雌二醇 3-甲醚, 3-甲氧基-17α-乙炔雌二醇
等级
pharmaceutical primary standard
API类
mestranol
制造商/商品名称
EDQM
mp
153-155 °C (lit.)
应用
pharmaceutical (small molecule)
包装形式
neat
储存温度
2-8°C
SMILES字符串
COc1ccc2C3CC[C@@]4(C)C(CC[C@@]4(O)C#C)C3CCc2c1
InChI
1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1
InChI key
IMSSROKUHAOUJS-MJCUULBUSA-N
基因信息
human ... ESR1(2099)
正在寻找类似产品? 访问 产品对比指南
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
包装
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他说明
Sales restrictions may apply.
警示用语：
Warning
危险声明
危险分类
Carc. 2 - Eye Irrit. 2 - Skin Irrit. 2
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
涉药品监管产品
此项目有
Mestranol.
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, 21, 257-278 (1979-12-01)
[Comparative study of the effect of ethinyl estradiol and mestranol. Clinical data from the literature].
R Pellegrini et al.
Quaderni di clinica ostetrica e ginecologica, 24(9), 597-617 (1969-09-01)
J W Goldzieher et al.
American journal of obstetrics and gynecology, 163(6 Pt 2), 2114-2119 (1990-12-01)
Pharmacokinetally, a 50 micrograms oral dose of mestranol (which itself is inactive) is bioequivalent to a 35 micrograms dose of ethinyl estradiol. Physiologically, mestranol ranges from 50% to 100% of the activity of ethinyl estradiol, depending on the endpoint chosen.
Si Wang et al.
Toxicological sciences : an official journal of the Society of Toxicology, 141(1), 78-89 (2014-06-15)
In the present study, a previously established integrated testing strategy (ITS) for in vitro estrogenicity testing was extended with additional in vitro assays in order to broaden its sensitivity to different modes of action resulting in apparent estrogenicity, i.e., other
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持